Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O KLEIN

Showing results (151-160 of 452) with videos related to

Pageof 46
Sort By:
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 22, 2008
Flexibility and dynamics of NhaA Na+/H+-antiporter of Escherichia coli studied by Fourier transform infrared spectroscopyE Dzafić, O Klein, E Screpanti, et al.
Pharmacopsychiatry|September 29, 2005
Scheme-based benzodiazepine detoxification with oxcarbazepine -- a case reportB Croissant, M Grosshans, O Klein, et al.
Neuro-Chirurgie|March 25, 2014
Suprasellar arachnoid cyst after subdural haemorrhage in an infant. A case based updateM-H Sonnet, A Joud, J-C Marchal, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 15, 2021
Importance of individualizing treatment decisions in girls with central precocious puberty when initiating treatment after age 7 years or continuing beyond a chronological age of 10 years or a bone age of 12 yearsMarcela Vargas Trujillo, Sanja Dragnic, Petra Aldridge, et al.
Reviews of Infectious Diseases|March 1, 1983
Selection of antimicrobial agents for treatment of neonatal sepsisJ O Klein, B Dashefsky, C R Norton, et al.
Investigational New Drugs|January 1, 1984
Preclinical evaluation of toxicity and therapeutic efficacy of a stabilized cytostatic metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide)H O Klein, P D Wickramanayake, E Christian, et al.
Infection|January 1, 1980
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteriaA DeMaria, S Alvarez, J O Klein, et al.
Harefuah|July 7, 2000
[Cortical blindness following coronary angiography]A Ron, S Meisel, M Shapiro-Feinberg, et al.
The Pediatric Infectious Disease Journal|March 27, 1999
Management of otitis media among children in a large health insurance planD Thompson, G Oster, L J McGarry, et al.
Current Medical Research and Opinion|November 29, 2019
A survey of care pathway and health-related quality of life impact for children with central precocious pubertyKaren O Klein, Ahmed M Soliman, ElizaBeth Grubb, et al.
Pageof 46

Showing results (151-160 of 452) with videos related to

Sort By:
Pageof 46
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 22, 2008
Flexibility and dynamics of NhaA Na+/H+-antiporter of Escherichia coli studied by Fourier transform infrared spectroscopyE Dzafić, O Klein, E Screpanti, et al.
Pharmacopsychiatry|September 29, 2005
Scheme-based benzodiazepine detoxification with oxcarbazepine -- a case reportB Croissant, M Grosshans, O Klein, et al.
Neuro-Chirurgie|March 25, 2014
Suprasellar arachnoid cyst after subdural haemorrhage in an infant. A case based updateM-H Sonnet, A Joud, J-C Marchal, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 15, 2021
Importance of individualizing treatment decisions in girls with central precocious puberty when initiating treatment after age 7 years or continuing beyond a chronological age of 10 years or a bone age of 12 yearsMarcela Vargas Trujillo, Sanja Dragnic, Petra Aldridge, et al.
Reviews of Infectious Diseases|March 1, 1983
Selection of antimicrobial agents for treatment of neonatal sepsisJ O Klein, B Dashefsky, C R Norton, et al.
Investigational New Drugs|January 1, 1984
Preclinical evaluation of toxicity and therapeutic efficacy of a stabilized cytostatic metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide)H O Klein, P D Wickramanayake, E Christian, et al.
Infection|January 1, 1980
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteriaA DeMaria, S Alvarez, J O Klein, et al.
Harefuah|July 7, 2000
[Cortical blindness following coronary angiography]A Ron, S Meisel, M Shapiro-Feinberg, et al.
The Pediatric Infectious Disease Journal|March 27, 1999
Management of otitis media among children in a large health insurance planD Thompson, G Oster, L J McGarry, et al.
Current Medical Research and Opinion|November 29, 2019
A survey of care pathway and health-related quality of life impact for children with central precocious pubertyKaren O Klein, Ahmed M Soliman, ElizaBeth Grubb, et al.
Pageof 46